Brief: Antisense Therapeutics Seeks Trading Halt
14/07/2023 24:13
July 14 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL
RAISING.
Source text for Eikon: ID:nASX2LDwZ8
Further company coverage: ANP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director